LEGISLATION

Compliance Alert: New Private-Pay Opioid Law Puts All Drug Addiction & Rehab Labs at Risk of Federal Prosecution

Recent federal legislation addressing the opioid crisis may have unintended consequences on the lab industry. The idea was to allow the feds to prosecute a certain kind of abuse banned by the … [Read more...]

LEGISLATION

Brief Your CEO: New Penalties Double the Dollar Value of Protecting Your Lab from Liability

You may not realize this, but Congress has just doubled the dollar value of what you do as a compliance manager to keep your lab out of federal health care fraud hot water. How? By significantly … [Read more...]

NEWS AT A GLANCE

Case of the Month: Feds Turn Up the Heat on False Billing of Nuclear Stress Tests

While the feds have made urine drug testing of opioid drug patients their number one target for lab-related False Claims Act (FCA) charges this year, nuclear stress tests (NSTs) ordered by … [Read more...]

LEGISLATION

PAMA-Geddon: Lab Industry Takes CMS to Court

The nearly three-year struggle between HHS and the lab industry over PAMA has entered a new phase. On December 11, the American Clinical Laboratory Association (ACLA) filed a lawsuit asking the U.S. … [Read more...]

LAB SAFETY

CLIA Corner: FDA Moves to Boost CLIA Waiver Transparency

The CLIA standards that a lab must meet are based on the complexity of the in vitro diagnostic tests it performs. The FDA's primary role in the CLIA system is to categorize IVDs. Test … [Read more...]

COMPLIANCE

Medicare Reimbursement: CMS Finalizes Hospital Outpatient Prospective Payment Changes for 2018

With all of the PAMA commotion, the 2018 Medicare Hospital and Ambulatory Surgical Outpatient Prospective Payment System (OPPS) final rule has flown under the radar. In case you don't feel like … [Read more...]

COMPLIANCE PERSPECTIVES

CMS Finalizes Controversial PAMA Fee Schedule

It's official. Brushing aside fierce lab industry opposition, CMS has decided to go forward with its PAMA Clinical Laboratory Fee Schedule (CLFS) in 2018. The Flawed Fee Schedule The intent of the … [Read more...]

NEWS AT A GLANCE

Case of the Month: Lab Tests Play Key Role in $19 Million Detroit Opioid Scheme

A physician just pleaded guilty to ordering millions in medically unnecessary lab tests? So what else is new? Please pass the butter… Granted, stories like the Oct. 12 guilty plea of that physician … [Read more...]

COMPLIANCE PERSPECTIVES

PAMA-Geddon: Proposed 2018 Lab Pay Rates Are a Bloodbath

There will be no delay; and And hospital labs will remain excluded from "applicable laboratories" on which supposed market rate payments for lab tests will be based. Those were the first … [Read more...]

BRIEF YOUR CEO

Help Your Lab Brace for Key Medicare Outpatient Reimbursement Changes

With the 2018 Clinical Laboratory Fee Schedule (CLFS) still in the works, CMS proposed changes to the Hospital Outpatient Prospective Payment System (HOPPS) rules on July 13. There are three items … [Read more...]


(-00000g2)